The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global RNA Analysis & Transcriptomic Market Research Report 2025
Synopsis
The global RNA Analysis & Transcriptomic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for RNA Analysis & Transcriptomic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for RNA Analysis & Transcriptomic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for RNA Analysis & Transcriptomic in Clinical Diagnostics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of RNA Analysis & Transcriptomic include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Fluidigm Corporation, Eurofins Scientific and Sequentia Biotech SL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for RNA Analysis & Transcriptomic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Analysis & Transcriptomic.
Report Scope
The RNA Analysis & Transcriptomic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNA Analysis & Transcriptomic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Analysis & Transcriptomic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Merck KGaA
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech SL
Acobiom
GenXPro GmbH
CD Genomics
Promega Corporation
Cenix BioScience GmbH
Takara Holdings, Inc.
bioMérieux SA
LC Sciences LLC
Segment by Type
Microarrays
Sequencing
Polymerase Chain Reaction
RNA Interference
Segment by Application
Clinical Diagnostics
Drug Discovery
Toxicogenomics
Comparative Transcriptomics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Analysis & Transcriptomic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global RNA Analysis & Transcriptomic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for RNA Analysis & Transcriptomic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for RNA Analysis & Transcriptomic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for RNA Analysis & Transcriptomic in Clinical Diagnostics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of RNA Analysis & Transcriptomic include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Fluidigm Corporation, Eurofins Scientific and Sequentia Biotech SL, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for RNA Analysis & Transcriptomic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Analysis & Transcriptomic.
Report Scope
The RNA Analysis & Transcriptomic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNA Analysis & Transcriptomic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Analysis & Transcriptomic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Merck KGaA
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech SL
Acobiom
GenXPro GmbH
CD Genomics
Promega Corporation
Cenix BioScience GmbH
Takara Holdings, Inc.
bioMérieux SA
LC Sciences LLC
Segment by Type
Microarrays
Sequencing
Polymerase Chain Reaction
RNA Interference
Segment by Application
Clinical Diagnostics
Drug Discovery
Toxicogenomics
Comparative Transcriptomics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Analysis & Transcriptomic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Analysis & Transcriptomic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Microarrays
1.2.3 Sequencing
1.2.4 Polymerase Chain Reaction
1.2.5 RNA Interference
1.3 Market by Application
1.3.1 Global RNA Analysis & Transcriptomic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Diagnostics
1.3.3 Drug Discovery
1.3.4 Toxicogenomics
1.3.5 Comparative Transcriptomics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Analysis & Transcriptomic Market Perspective (2019-2030)
2.2 RNA Analysis & Transcriptomic Growth Trends by Region
2.2.1 Global RNA Analysis & Transcriptomic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 RNA Analysis & Transcriptomic Historic Market Size by Region (2019-2024)
2.2.3 RNA Analysis & Transcriptomic Forecasted Market Size by Region (2025-2030)
2.3 RNA Analysis & Transcriptomic Market Dynamics
2.3.1 RNA Analysis & Transcriptomic Industry Trends
2.3.2 RNA Analysis & Transcriptomic Market Drivers
2.3.3 RNA Analysis & Transcriptomic Market Challenges
2.3.4 RNA Analysis & Transcriptomic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Analysis & Transcriptomic Players by Revenue
3.1.1 Global Top RNA Analysis & Transcriptomic Players by Revenue (2019-2024)
3.1.2 Global RNA Analysis & Transcriptomic Revenue Market Share by Players (2019-2024)
3.2 Global RNA Analysis & Transcriptomic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA Analysis & Transcriptomic Revenue
3.4 Global RNA Analysis & Transcriptomic Market Concentration Ratio
3.4.1 Global RNA Analysis & Transcriptomic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Analysis & Transcriptomic Revenue in 2023
3.5 RNA Analysis & Transcriptomic Key Players Head office and Area Served
3.6 Key Players RNA Analysis & Transcriptomic Product Solution and Service
3.7 Date of Enter into RNA Analysis & Transcriptomic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Analysis & Transcriptomic Breakdown Data by Type
4.1 Global RNA Analysis & Transcriptomic Historic Market Size by Type (2019-2024)
4.2 Global RNA Analysis & Transcriptomic Forecasted Market Size by Type (2025-2030)
5 RNA Analysis & Transcriptomic Breakdown Data by Application
5.1 Global RNA Analysis & Transcriptomic Historic Market Size by Application (2019-2024)
5.2 Global RNA Analysis & Transcriptomic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America RNA Analysis & Transcriptomic Market Size (2019-2030)
6.2 North America RNA Analysis & Transcriptomic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America RNA Analysis & Transcriptomic Market Size by Country (2019-2024)
6.4 North America RNA Analysis & Transcriptomic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Analysis & Transcriptomic Market Size (2019-2030)
7.2 Europe RNA Analysis & Transcriptomic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe RNA Analysis & Transcriptomic Market Size by Country (2019-2024)
7.4 Europe RNA Analysis & Transcriptomic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Analysis & Transcriptomic Market Size (2019-2030)
8.2 Asia-Pacific RNA Analysis & Transcriptomic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2019-2024)
8.4 Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Analysis & Transcriptomic Market Size (2019-2030)
9.2 Latin America RNA Analysis & Transcriptomic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America RNA Analysis & Transcriptomic Market Size by Country (2019-2024)
9.4 Latin America RNA Analysis & Transcriptomic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Analysis & Transcriptomic Market Size (2019-2030)
10.2 Middle East & Africa RNA Analysis & Transcriptomic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2019-2024)
10.4 Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Detail
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. RNA Analysis & Transcriptomic Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.1.5 Thermo Fisher Scientific, Inc. Recent Development
11.2 Bio-Rad Laboratories, Inc.
11.2.1 Bio-Rad Laboratories, Inc. Company Detail
11.2.2 Bio-Rad Laboratories, Inc. Business Overview
11.2.3 Bio-Rad Laboratories, Inc. RNA Analysis & Transcriptomic Introduction
11.2.4 Bio-Rad Laboratories, Inc. Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.2.5 Bio-Rad Laboratories, Inc. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA RNA Analysis & Transcriptomic Introduction
11.3.4 Merck KGaA Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.3.5 Merck KGaA Recent Development
11.4 Agilent Technologies, Inc.
11.4.1 Agilent Technologies, Inc. Company Detail
11.4.2 Agilent Technologies, Inc. Business Overview
11.4.3 Agilent Technologies, Inc. RNA Analysis & Transcriptomic Introduction
11.4.4 Agilent Technologies, Inc. Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.4.5 Agilent Technologies, Inc. Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Detail
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. RNA Analysis & Transcriptomic Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Detail
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation RNA Analysis & Transcriptomic Introduction
11.6.4 Danaher Corporation Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.6.5 Danaher Corporation Recent Development
11.7 Fluidigm Corporation
11.7.1 Fluidigm Corporation Company Detail
11.7.2 Fluidigm Corporation Business Overview
11.7.3 Fluidigm Corporation RNA Analysis & Transcriptomic Introduction
11.7.4 Fluidigm Corporation Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.7.5 Fluidigm Corporation Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Detail
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific RNA Analysis & Transcriptomic Introduction
11.8.4 Eurofins Scientific Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.8.5 Eurofins Scientific Recent Development
11.9 Sequentia Biotech SL
11.9.1 Sequentia Biotech SL Company Detail
11.9.2 Sequentia Biotech SL Business Overview
11.9.3 Sequentia Biotech SL RNA Analysis & Transcriptomic Introduction
11.9.4 Sequentia Biotech SL Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.9.5 Sequentia Biotech SL Recent Development
11.10 Acobiom
11.10.1 Acobiom Company Detail
11.10.2 Acobiom Business Overview
11.10.3 Acobiom RNA Analysis & Transcriptomic Introduction
11.10.4 Acobiom Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.10.5 Acobiom Recent Development
11.11 GenXPro GmbH
11.11.1 GenXPro GmbH Company Detail
11.11.2 GenXPro GmbH Business Overview
11.11.3 GenXPro GmbH RNA Analysis & Transcriptomic Introduction
11.11.4 GenXPro GmbH Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.11.5 GenXPro GmbH Recent Development
11.12 CD Genomics
11.12.1 CD Genomics Company Detail
11.12.2 CD Genomics Business Overview
11.12.3 CD Genomics RNA Analysis & Transcriptomic Introduction
11.12.4 CD Genomics Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.12.5 CD Genomics Recent Development
11.13 Promega Corporation
11.13.1 Promega Corporation Company Detail
11.13.2 Promega Corporation Business Overview
11.13.3 Promega Corporation RNA Analysis & Transcriptomic Introduction
11.13.4 Promega Corporation Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.13.5 Promega Corporation Recent Development
11.14 Cenix BioScience GmbH
11.14.1 Cenix BioScience GmbH Company Detail
11.14.2 Cenix BioScience GmbH Business Overview
11.14.3 Cenix BioScience GmbH RNA Analysis & Transcriptomic Introduction
11.14.4 Cenix BioScience GmbH Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.14.5 Cenix BioScience GmbH Recent Development
11.15 Takara Holdings, Inc.
11.15.1 Takara Holdings, Inc. Company Detail
11.15.2 Takara Holdings, Inc. Business Overview
11.15.3 Takara Holdings, Inc. RNA Analysis & Transcriptomic Introduction
11.15.4 Takara Holdings, Inc. Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.15.5 Takara Holdings, Inc. Recent Development
11.16 bioMérieux SA
11.16.1 bioMérieux SA Company Detail
11.16.2 bioMérieux SA Business Overview
11.16.3 bioMérieux SA RNA Analysis & Transcriptomic Introduction
11.16.4 bioMérieux SA Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.16.5 bioMérieux SA Recent Development
11.17 LC Sciences LLC
11.17.1 LC Sciences LLC Company Detail
11.17.2 LC Sciences LLC Business Overview
11.17.3 LC Sciences LLC RNA Analysis & Transcriptomic Introduction
11.17.4 LC Sciences LLC Revenue in RNA Analysis & Transcriptomic Business (2019-2024)
11.17.5 LC Sciences LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global RNA Analysis & Transcriptomic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Microarrays
Table 3. Key Players of Sequencing
Table 4. Key Players of Polymerase Chain Reaction
Table 5. Key Players of RNA Interference
Table 6. Global RNA Analysis & Transcriptomic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global RNA Analysis & Transcriptomic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global RNA Analysis & Transcriptomic Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global RNA Analysis & Transcriptomic Market Share by Region (2019-2024)
Table 10. Global RNA Analysis & Transcriptomic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global RNA Analysis & Transcriptomic Market Share by Region (2025-2030)
Table 12. RNA Analysis & Transcriptomic Market Trends
Table 13. RNA Analysis & Transcriptomic Market Drivers
Table 14. RNA Analysis & Transcriptomic Market Challenges
Table 15. RNA Analysis & Transcriptomic Market Restraints
Table 16. Global RNA Analysis & Transcriptomic Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global RNA Analysis & Transcriptomic Market Share by Players (2019-2024)
Table 18. Global Top RNA Analysis & Transcriptomic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Analysis & Transcriptomic as of 2023)
Table 19. Ranking of Global Top RNA Analysis & Transcriptomic Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by RNA Analysis & Transcriptomic Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players RNA Analysis & Transcriptomic Product Solution and Service
Table 23. Date of Enter into RNA Analysis & Transcriptomic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global RNA Analysis & Transcriptomic Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global RNA Analysis & Transcriptomic Revenue Market Share by Type (2019-2024)
Table 27. Global RNA Analysis & Transcriptomic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global RNA Analysis & Transcriptomic Revenue Market Share by Type (2025-2030)
Table 29. Global RNA Analysis & Transcriptomic Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global RNA Analysis & Transcriptomic Revenue Market Share by Application (2019-2024)
Table 31. Global RNA Analysis & Transcriptomic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global RNA Analysis & Transcriptomic Revenue Market Share by Application (2025-2030)
Table 33. North America RNA Analysis & Transcriptomic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America RNA Analysis & Transcriptomic Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America RNA Analysis & Transcriptomic Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe RNA Analysis & Transcriptomic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe RNA Analysis & Transcriptomic Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe RNA Analysis & Transcriptomic Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific RNA Analysis & Transcriptomic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America RNA Analysis & Transcriptomic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America RNA Analysis & Transcriptomic Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America RNA Analysis & Transcriptomic Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa RNA Analysis & Transcriptomic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country (2025-2030) & (US$ Million)
Table 48. Thermo Fisher Scientific, Inc. Company Detail
Table 49. Thermo Fisher Scientific, Inc. Business Overview
Table 50. Thermo Fisher Scientific, Inc. RNA Analysis & Transcriptomic Product
Table 51. Thermo Fisher Scientific, Inc. Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 52. Thermo Fisher Scientific, Inc. Recent Development
Table 53. Bio-Rad Laboratories, Inc. Company Detail
Table 54. Bio-Rad Laboratories, Inc. Business Overview
Table 55. Bio-Rad Laboratories, Inc. RNA Analysis & Transcriptomic Product
Table 56. Bio-Rad Laboratories, Inc. Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 57. Bio-Rad Laboratories, Inc. Recent Development
Table 58. Merck KGaA Company Detail
Table 59. Merck KGaA Business Overview
Table 60. Merck KGaA RNA Analysis & Transcriptomic Product
Table 61. Merck KGaA Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 62. Merck KGaA Recent Development
Table 63. Agilent Technologies, Inc. Company Detail
Table 64. Agilent Technologies, Inc. Business Overview
Table 65. Agilent Technologies, Inc. RNA Analysis & Transcriptomic Product
Table 66. Agilent Technologies, Inc. Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 67. Agilent Technologies, Inc. Recent Development
Table 68. F. Hoffmann-La Roche Ltd. Company Detail
Table 69. F. Hoffmann-La Roche Ltd. Business Overview
Table 70. F. Hoffmann-La Roche Ltd. RNA Analysis & Transcriptomic Product
Table 71. F. Hoffmann-La Roche Ltd. Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 72. F. Hoffmann-La Roche Ltd. Recent Development
Table 73. Danaher Corporation Company Detail
Table 74. Danaher Corporation Business Overview
Table 75. Danaher Corporation RNA Analysis & Transcriptomic Product
Table 76. Danaher Corporation Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 77. Danaher Corporation Recent Development
Table 78. Fluidigm Corporation Company Detail
Table 79. Fluidigm Corporation Business Overview
Table 80. Fluidigm Corporation RNA Analysis & Transcriptomic Product
Table 81. Fluidigm Corporation Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 82. Fluidigm Corporation Recent Development
Table 83. Eurofins Scientific Company Detail
Table 84. Eurofins Scientific Business Overview
Table 85. Eurofins Scientific RNA Analysis & Transcriptomic Product
Table 86. Eurofins Scientific Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 87. Eurofins Scientific Recent Development
Table 88. Sequentia Biotech SL Company Detail
Table 89. Sequentia Biotech SL Business Overview
Table 90. Sequentia Biotech SL RNA Analysis & Transcriptomic Product
Table 91. Sequentia Biotech SL Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 92. Sequentia Biotech SL Recent Development
Table 93. Acobiom Company Detail
Table 94. Acobiom Business Overview
Table 95. Acobiom RNA Analysis & Transcriptomic Product
Table 96. Acobiom Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 97. Acobiom Recent Development
Table 98. GenXPro GmbH Company Detail
Table 99. GenXPro GmbH Business Overview
Table 100. GenXPro GmbH RNA Analysis & Transcriptomic Product
Table 101. GenXPro GmbH Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 102. GenXPro GmbH Recent Development
Table 103. CD Genomics Company Detail
Table 104. CD Genomics Business Overview
Table 105. CD Genomics RNA Analysis & Transcriptomic Product
Table 106. CD Genomics Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 107. CD Genomics Recent Development
Table 108. Promega Corporation Company Detail
Table 109. Promega Corporation Business Overview
Table 110. Promega Corporation RNA Analysis & Transcriptomic Product
Table 111. Promega Corporation Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 112. Promega Corporation Recent Development
Table 113. Cenix BioScience GmbH Company Detail
Table 114. Cenix BioScience GmbH Business Overview
Table 115. Cenix BioScience GmbH RNA Analysis & Transcriptomic Product
Table 116. Cenix BioScience GmbH Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 117. Cenix BioScience GmbH Recent Development
Table 118. Takara Holdings, Inc. Company Detail
Table 119. Takara Holdings, Inc. Business Overview
Table 120. Takara Holdings, Inc. RNA Analysis & Transcriptomic Product
Table 121. Takara Holdings, Inc. Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 122. Takara Holdings, Inc. Recent Development
Table 123. bioMérieux SA Company Detail
Table 124. bioMérieux SA Business Overview
Table 125. bioMérieux SA RNA Analysis & Transcriptomic Product
Table 126. bioMérieux SA Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 127. bioMérieux SA Recent Development
Table 128. LC Sciences LLC Company Detail
Table 129. LC Sciences LLC Business Overview
Table 130. LC Sciences LLC RNA Analysis & Transcriptomic Product
Table 131. LC Sciences LLC Revenue in RNA Analysis & Transcriptomic Business (2019-2024) & (US$ Million)
Table 132. LC Sciences LLC Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNA Analysis & Transcriptomic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global RNA Analysis & Transcriptomic Market Share by Type: 2023 VS 2030
Figure 3. Microarrays Features
Figure 4. Sequencing Features
Figure 5. Polymerase Chain Reaction Features
Figure 6. RNA Interference Features
Figure 7. Global RNA Analysis & Transcriptomic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global RNA Analysis & Transcriptomic Market Share by Application: 2023 VS 2030
Figure 9. Clinical Diagnostics Case Studies
Figure 10. Drug Discovery Case Studies
Figure 11. Toxicogenomics Case Studies
Figure 12. Comparative Transcriptomics Case Studies
Figure 13. RNA Analysis & Transcriptomic Report Years Considered
Figure 14. Global RNA Analysis & Transcriptomic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global RNA Analysis & Transcriptomic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global RNA Analysis & Transcriptomic Market Share by Region: 2023 VS 2030
Figure 17. Global RNA Analysis & Transcriptomic Market Share by Players in 2023
Figure 18. Global Top RNA Analysis & Transcriptomic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Analysis & Transcriptomic as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by RNA Analysis & Transcriptomic Revenue in 2023
Figure 20. North America RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America RNA Analysis & Transcriptomic Market Share by Country (2019-2030)
Figure 22. United States RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe RNA Analysis & Transcriptomic Market Share by Country (2019-2030)
Figure 26. Germany RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific RNA Analysis & Transcriptomic Market Share by Region (2019-2030)
Figure 34. China RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America RNA Analysis & Transcriptomic Market Share by Country (2019-2030)
Figure 42. Mexico RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa RNA Analysis & Transcriptomic Market Share by Country (2019-2030)
Figure 46. Turkey RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia RNA Analysis & Transcriptomic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Thermo Fisher Scientific, Inc. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 49. Bio-Rad Laboratories, Inc. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 50. Merck KGaA Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 51. Agilent Technologies, Inc. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 52. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 53. Danaher Corporation Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 54. Fluidigm Corporation Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 55. Eurofins Scientific Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 56. Sequentia Biotech SL Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 57. Acobiom Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 58. GenXPro GmbH Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 59. CD Genomics Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 60. Promega Corporation Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 61. Cenix BioScience GmbH Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 62. Takara Holdings, Inc. Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 63. bioMérieux SA Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 64. LC Sciences LLC Revenue Growth Rate in RNA Analysis & Transcriptomic Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Retail Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
